(Q39828223)

15 September 2017

Clinical efficacy and levels of ciprofloxacin in tissue in patients with soft tissue infection (English)

1 reference

15 September 2017

Licitra CM

1

1 reference

15 September 2017

Brooks RG

series ordinal

2

1 reference

15 September 2017

Sieger BE

series ordinal

3

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 May 1987

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

31

1 reference

15 September 2017

5

1 reference

15 September 2017

805-807

1 reference

Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174837

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174837

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174837

Ciprofloxacin therapy of infections caused by Pseudomonas aeruginosa and other resistant bacteria

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174837

Open, prospective study of the clinical efficacy of ciprofloxacin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174837

Pharmacokinetics and tissue penetration of ciprofloxacin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174837

Efficacy and safety of ciprofloxacin (Bay 0 9867) in the treatment of patients with complicated urinary tract infections.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174837

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174837

Ciprofloxacin distribution in prostatic tissue and fluid following oral administration

17 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3606079

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tissue distribution of ciprofloxacin following oral and intravenous administration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3606079

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.31.5.805

1 reference

15 September 2017

1 reference

15 September 2017

1 reference